Loading clinical trials...

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00050609

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying

The purposes of this study are to determine whether an experimental drug known as tadalafil can reduce symptoms of dyspepsia (fullness after eating, inability to finish a regular meal, bloating, disco...

Lead sponsor: Eli Lilly and Company•12 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGEARLY Phase 1

Growth Hormone for the Treatment of Gastroparesis

NCT06803589 · Gastroparesis

RECRUITING

Study of Gastric Motility in Eosinophilic Gastritis

NCT05229432 · Eosinophilic Gastritis, Gastroparesis, and more

RECRUITING

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

NCT03876288 · Gastroparesis

RECRUITINGNA

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

NCT07287943 · Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I

RECRUITING

Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

NCT07324785 · Diabetic Gastroparesis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 20, 2007Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment2

Start dateFeb 2003

Last updatedNov 20, 2007

Condition

Gastroparesis

Locations shown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Edmonton, Alberta

Vancouver, British Columbia

Victoria, British Columbia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 20, 2007Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Growth Hormone for the Treatment of Gastroparesis

Study of Gastric Motility in Eosinophilic Gastritis

Gastroparesis Outcome Longitudinal Database Enrolled Numerically

To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

Trial snapshot

Condition

Locations shown

For caregivers